NetworkNewsBreaks Archive - Page 183 of 2120

MondayApr 28, 2025 10:15 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering

BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering of 3,066,666 units at $4.50 per unit for gross proceeds of approximately $13.8 million. Each unit includes one common share or pre-funded warrant and one warrant exercisable at $5.25 per share. The offering, led by ThinkEquity, is expected to close on April 28, 2025, subject to customary conditions. BriaCell plans to use the net proceeds for working capital, corporate purposes and advancing business objectives. To view the full article, visit https://nnw.fm/bi0fN About BriaCell Therapeutics BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to…

MondayApr 28, 2025 9:48 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Showcases ADIO® Technology at NFL Alumni Health Draft Week Event

Datavault AI (NASDAQ: DVLT) highlighted its ADIO® tone technology at NFL Alumni Health’s 16th Annual Draft Week event on April 24, 2025, delivering interactive tones synced with top draft picks and geo-targeted health messages across the venue. The platform enabled real-time fan engagement without screens or manual input and supported cardiovascular health awareness for former athletes. Datavault AI’s deployment demonstrated how AI-powered tone technology can deepen audience interaction and create new monetization opportunities at major live events. To view the full press release, visit https://nnw.fm/w3D52 About Datavault AI Inc. Datavault AI (Nasdaq: DVLT) is leading the way in AI experience, valuation,…

MondayApr 28, 2025 9:31 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances RTNova Platform with IL15 Superagonist Payload

Calidi Biotherapeutics (NYSE American: CLDI) announced the selection of IL15 superagonist (IL15-IL15Ra) as the first therapeutic payload for its systemic antitumor virotherapy platform, RTNova. Preclinical data presented at the AACR Annual Meeting show that Calidi's engineered vaccinia virus can deliver IL15 superagonist directly into the tumor microenvironment, significantly boosting immune response and tumor elimination while minimizing systemic toxicity. The RTNova platform aims to treat metastatic cancers by enabling systemic delivery of tumor-targeted virotherapies. To view the full press release, visit: https://nnw.fm/m7Yjj About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s…

FridayApr 25, 2025 3:59 pm

NetworkNewsBreaks – Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, was featured in a recent article that discussed its innovative AVERSA(TM) abuse-deterrent technology and business model. “AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao,” the article reads. “The company’s…

FridayApr 25, 2025 1:53 pm

NetworkNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project Poised to Fuel Modern Tech with Critical PGMs

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself to become a key player in the expanding platinum group metals (“PGMs”) sector, driven by the essential role of PGMs in next-gen technology and industrial applications. PGMs serve critical functions in catalytic converters, fuel cells, catalysts in various industrial processes, electronics and the medical sector. These metals are also expected to play an even more crucial role in advancing sustainable technologies amid global efforts to reduce carbon emissions. The company’s Waterberg Project, located in South Africa’s renowned Bushveld Complex, is a large-scale, low-cost, bulk-mineable deposit with a particular focus…

FridayApr 25, 2025 1:40 pm

NetworkNewsBreaks – Newton Golf Company (NASDAQ: NWTG) Gains Momentum on Champions Tour with Golf.com Spotlight

Newton Golf Company Inc. (NASDAQ: NWTG), a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design, has seen its Newton Motion shafts rapidly gain popularity on the Champions Tour, recently earning a feature on Golf.com for their innovative performance benefits tailored to senior players. The shafts utilize a unique variable stiffness profile—more flexible in the midsection and stiffer at the tip and butt ends—resulting in improved energy transfer, higher launch angles, and increased distance. These design advantages have made them a go-to choice for many veteran professionals seeking more consistency and power in their drives. To read…

FridayApr 25, 2025 10:30 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Report First Quarter Fiscal Year 2025 Financial Results on May 8

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software, and services, will release its first-quarter fiscal 2025 results before market open on Thursday, May 8, 2025. D-Wave will host a conference call featuring CEO Dr. Alan Baratz and CFO John Markovich at 8:00 a.m. ET that day to discuss financial results and business outlook. The earnings press release and webcast replay will be available on the D-Wave Investor Relations website. To view the full press release, visit https://nnw.fm/GMcLc. About D-Wave Quantum Inc. D-Wave is a leader in the development and delivery of quantum computing…

FridayApr 25, 2025 9:51 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Grants Inducement Stock Option to New CEO Eric Poma

Calidi Biotherapeutics (NYSE American: CLDI) a clinical-stage biotechnology company advancing targeted antitumor virotherapies, announced the approval of an inducement non-qualified stock option grant to new Chief Executive Officer Eric Poma, Ph.D. The grant includes the option to purchase 726,412 shares at an exercise price of $0.469, the closing price of Calidi’s common stock on April 22, 2025. The options will vest over four years, with 25% vesting on April 22, 2026, and the remainder vesting in equal monthly installments through April 22, 2029, in accordance with Section 711 of the NYSE American LLC Company Guide. To view the full press…

FridayApr 25, 2025 9:00 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in Benzinga Video Highlighting 75% HyBryte™ Response Rate in FDA-Backed Skin Cancer Trial

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, is featured in a new Benzinga video detailing clinical progress for its lead candidate HyBryte™, which achieved a 75% response rate in a trial for cutaneous T-cell lymphoma (CTCL), a rare form of skin cancer. The trial is supported by funding from a U.S. Food and Drug Administration’s Orphan Products Development Grant and showcases HyBryte’s™ potential as a first-in-class, light-activated, non-invasive therapy. HyBryte™ is a first-in-class photodynamic therapy activated by safe visible light and has previously received Orphan Drug and Fast Track designations. Soligenix plans to continue advancing regulatory…

ThursdayApr 24, 2025 3:15 pm

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Aligns Strategy to Drive Long-Term Growth

Massimo Group (NASDAQ: MAMO), a manufacturer of powersports vehicles, is reinforcing its market position through strategic retail partnerships and a commitment to quality and innovation. By participating in key industry events like the Rural King Vendor Summit, the Tractor Supply Company and PetSense Annual Supplier Meeting and the Partner Trade Show, Massimo deepens ties with major retailers, gaining insights into customer needs and market trends. CEO David Shan emphasizes the company’s dedication to serving consumers who value reliable, high-performance products. Alongside expanding its reach through retail collaborations and a new online sales platform, Massimo enhanced operational efficiency by relocating its…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks